These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 11039338)

  • 1. Effects of three different doses of a bolus injection of gadodiamide: assessment of regional cerebral blood volume maps in a blinded reader study.
    Bruening R; Berchtenbreiter C; Holzknecht N; Essig M; Wu RH; Simmons A; Heuck A; Maschek A; Meusel M; Williams SC; Cox T; Knopp MV; Reiser M
    AJNR Am J Neuroradiol; 2000 Oct; 21(9):1603-10. PubMed ID: 11039338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Echo-planar MR determination of relative cerebral blood volume in human brain tumors: T1 versus T2 weighting.
    Bruening R; Kwong KK; Vevea MJ; Hochberg FH; Cher L; Harsh GR; Niemi PT; Weisskoff RM; Rosen BR
    AJNR Am J Neuroradiol; 1996 May; 17(5):831-40. PubMed ID: 8733954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contrast-enhanced magnetic resonance angiography of the lower extremities: standard-dose vs. high-dose gadodiamide injection.
    Krause U; Kroencke T; Spielhaupter E; Taupitz M; Kenn W; Hamm B; Hahn D
    J Magn Reson Imaging; 2005 Apr; 21(4):449-54. PubMed ID: 15778953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double-blind, efficacy evaluation of gadobenate dimeglumine, a gadolinium chelate with enhanced relaxivity, in malignant lesions of the brain.
    Runge VM; Parker JR; Donovan M
    Invest Radiol; 2002 May; 37(5):269-80. PubMed ID: 11979153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three-dimensional dynamic susceptibility-weighted perfusion MR imaging at 3.0 T: feasibility and contrast agent dose.
    Manka C; Träber F; Gieseke J; Schild HH; Kuhl CK
    Radiology; 2005 Mar; 234(3):869-77. PubMed ID: 15665227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of first-pass and second-bolus dynamic susceptibility perfusion MRI in brain tumors.
    Spampinato MV; Wooten C; Dorlon M; Besenski N; Rumboldt Z
    Neuroradiology; 2006 Dec; 48(12):867-74. PubMed ID: 17013587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain metastases--comparison of gadodiamide injection-enhanced MR imaging at standard and high dose, contrast-enhanced CT and non-contrast-enhanced MR imaging.
    Akeson P; Larsson EM; Kristoffersen DT; Jonsson E; Holtås S
    Acta Radiol; 1995 May; 36(3):300-6. PubMed ID: 7742127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A clinical comparison of the safety and efficacy of MultiHance (gadobenate dimeglumine) and Omniscan (Gadodiamide) in magnetic resonance imaging in patients with central nervous system pathology.
    Runge VM; Armstrong MR; Barr RG; Berger BL; Czervionke LF; Gonzalez CF; Halford HH; Kanal E; Kuhn MJ; Levin JM; Low RN; Tanenbaum LN; Wang AM; Wong W; Yuh WT; Zoarski GH
    Invest Radiol; 2001 Feb; 36(2):65-71. PubMed ID: 11224753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved perfusion MR imaging assessment of intracerebral tumor blood volume and antiangiogenic therapy efficacy in a rat model with ferumoxytol.
    Gahramanov S; Muldoon LL; Li X; Neuwelt EA
    Radiology; 2011 Dec; 261(3):796-804. PubMed ID: 21940504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of cerebral blood volume with dynamic susceptibility contrast enhanced gradient-echo imaging.
    Gückel F; Brix G; Rempp K; Deimling M; Röther J; Georgi M
    J Comput Assist Tomogr; 1994; 18(3):344-51. PubMed ID: 8188897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A model of the dual effect of gadopentetate dimeglumine on dynamic brain MR images.
    Barbier EL; den Boer JA; Peters AR; Rozeboom AR; Sau J; Bonmartin A
    J Magn Reson Imaging; 1999 Sep; 10(3):242-53. PubMed ID: 10508283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of gadodiamide (Gd-DTPA-BMA) in renal 3D-magnetic resonance angiography (MRA): a phase II study.
    Kittner T; Rudolf J; Fages JF; Legmann P; Aschauer M; Repa I; Alvares MR; Savalegui I; Ittrich H; Geterud K; de Kevviler E; Ayuso J; Lockhart ME; Blum A; Iliasch H; Leisinger G; van Beek EJ; Reid AW; Brown JJ; Yu TC; Flamm SD; Düber C; Judmaier W; Reimer P; Stiskal M; Kramann B; Wolff S; Blankenstein C
    Eur J Radiol; 2007 Dec; 64(3):456-64. PubMed ID: 17412546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Studies on contrast medium dosage in perfusion-weighted MR imaging].
    Erb G; Benner T; Heiland S; Reith W; Sartor K; Forsting M
    Rofo; 1997 Dec; 167(6):599-604. PubMed ID: 9465955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebral blood volume maps with dynamic contrast-enhanced T1-weighted FLASH imaging: normal values and preliminary clinical results.
    Hackländer T; Hofer M; Reichenbach JR; Rascher K; Fürst G; Mödder U
    J Comput Assist Tomogr; 1996; 20(4):532-9. PubMed ID: 8708051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose Finding Study of Gadopiclenol, a New Macrocyclic Contrast Agent, in MRI of Central Nervous System.
    Bendszus M; Roberts D; Kolumban B; Meza JA; Bereczki D; San-Juan D; Liu BP; Anzalone N; Maravilla K
    Invest Radiol; 2020 Mar; 55(3):129-137. PubMed ID: 31917762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the diagnostic information in relative cerebral blood volume, maximum concentration, and subtraction signal intensity maps based on magnetic resonance imaging of gliomas.
    Berchtenbreiter C; Bruening R; Wu RH; Penzkofer H; Weber J; Reiser M
    Invest Radiol; 1999 Jan; 34(1):75-81. PubMed ID: 9888058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gadolinium Presence in the Brain After Administration of the Liver-Specific Gadolinium-Based Contrast Agent Gadoxetate: A Systematic Comparison to Multipurpose Agents in Rats.
    Jost G; Frenzel T; Boyken J; Schoeckel L; Pietsch H
    Invest Radiol; 2019 Aug; 54(8):468-474. PubMed ID: 30932931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myocardial perfusion imaging using OMNISCAN: a dose finding study for visual assessment of stress-induced regional perfusion abnormalities.
    Paetsch I; Föll D; Langreck H; Herkommer B; Klein C; Schalla S; Fleck E; Nagel E
    J Cardiovasc Magn Reson; 2004; 6(4):803-9. PubMed ID: 15646883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of gadodiamide versus gadobutrol for contrast-enhanced MR imaging in a rat brain glioma model at 1.5 and 3 T.
    Morelli JN; Runge VM; Vu L; Loynachan AT; Attenberger UI
    Invest Radiol; 2010 Dec; 45(12):810-8. PubMed ID: 20856127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of relative permeability and relative cerebral blood volume in high-grade cerebral neoplasms.
    Provenzale JM; York G; Moya MG; Parks L; Choma M; Kealey S; Cole P; Serajuddin H
    AJR Am J Roentgenol; 2006 Oct; 187(4):1036-42. PubMed ID: 16985154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.